Return to search

Dasatinib inhibits proliferation and activation of CD8+ T-lymphocytes by down-regulation of the T-cell receptor signaling

Ulm, Univ., Diss., 2007.

Identiferoai:union.ndltd.org:OCLC/oai:xtcat.oclc.org:OCLCNo/315427690
Date January 2007
CreatorsFei, Fei.
Publisher[S.l. : s.n.],
Source SetsOCLC
LanguageEnglish
Detected LanguageEnglish
TypeOnline-Publikation.
SourceKostenfrei

Page generated in 0.0021 seconds